Black Joel A, Nikolajsen Lone, Kroner Karsten, Jensen Troels S, Waxman Stephen G
Department of Neurology and Center for Neuroscience and Regeneration Research, Yale School of Medicine, New Haven, USA.
Ann Neurol. 2008 Dec;64(6):644-53. doi: 10.1002/ana.21527.
Although axons within neuromas have been shown to produce inappropriate spontaneous ectopic discharges, the molecular basis for pain in patients with neuromas is still not fully understood. Because sodium channels are known to play critical roles in neuronal electrogenesis and hyperexcitability, we examined the expression of all the neuronal voltage-gated sodium channels (Nav1.1, Nav1.2, Nav1.3, Nav1.6, Nav1.7, Nav1.8, and Nav1.9) within human painful neuromas. We also examined the expression of two mitogen-activated protein (MAP) kinases, activated p38 and extracellular signal-regulated kinases 1 and 2 (ERK1/2), which are known to contribute to chronic pain, within these human neuromas.
We used immunocytochemical methods with specific antibodies to sodium channels Nav1.1, Nav1.2, Nav1.3, Nav1.6, Nav1.7, Nav1.8, and Nav1.9, and to activated MAP kinases p38 and ERK1/2 to study by confocal microscopy control and painful neuroma tissue from five patients with well-documented pain.
We demonstrate upregulation of sodium channel Nav1.3, as well as Nav1.7 and Nav1.8, in blind-ending axons within human painful neuromas. We also demonstrate upregulation of activated p38 and ERK1/2 MAP kinases in axons within these neuromas.
These results demonstrate that multiple sodium channel isoforms (Nav1.3, Nav1.7, and Nav1.8), as well as activated p38 and ERK1/2 MAP kinases, are expressed in painful human neuromas, indicating that these molecules merit study as possible therapeutic targets for the treatment of pain associated with traumatic neuromas.
尽管已表明神经瘤内的轴突会产生不适当的自发性异位放电,但神经瘤患者疼痛的分子基础仍未完全明确。由于已知钠通道在神经元电活动和兴奋性过高方面起关键作用,我们检测了人类疼痛性神经瘤内所有神经元电压门控钠通道(Nav1.1、Nav1.2、Nav1.3、Nav1.6、Nav1.7、Nav1.8和Nav1.9)的表达。我们还检测了两种丝裂原活化蛋白(MAP)激酶,即活化的p38以及细胞外信号调节激酶1和2(ERK1/2)在这些人类神经瘤内的表达,已知这些激酶与慢性疼痛有关。
我们使用针对钠通道Nav1.1、Nav1.2、Nav1.3、Nav1.6、Nav1.7、Nav1.8和Nav1.9以及活化的MAP激酶p38和ERK1/2的特异性抗体,通过免疫细胞化学方法,利用共聚焦显微镜研究了来自五名有明确疼痛记录患者的对照和疼痛性神经瘤组织。
我们证实在人类疼痛性神经瘤内的盲端轴突中,钠通道Nav1.3以及Nav1.7和Nav1.8上调。我们还证实在这些神经瘤的轴突中活化的p38和ERK1/2 MAP激酶上调。
这些结果表明多种钠通道亚型(Nav1.3、Nav1.7和Nav1.8)以及活化的p38和ERK1/2 MAP激酶在人类疼痛性神经瘤中表达,这表明这些分子作为治疗与创伤性神经瘤相关疼痛的可能治疗靶点值得研究。